人类胚胎干细胞市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按应用(再生医学、干细胞生物学研究、组织工程和毒理学测试)和地理划分

市场快照

human embryonic stem cells market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.29 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于再生医学在器官移植、组织工程和其他各种应用中的应用,大多数发达国家政府对再生医学发展的资助一直在增加。在美国,美国国立卫生研究院 (NIH) 和加州再生医学研究所 (CIRM) 这两个主要政府机构资助了该国几乎所有的转化研究和再生医学发展。据估计,美国政府每年在干细胞研究方面的投资约为 800-9 亿美元。此外,其他因素,如心脏病和恶性疾病的高发病率,以及对再生药物的需求不断增长,预计将推动市场。

报告范围

根据报告的范围,人类胚胎干细胞是一种多能干细胞,来源于早期植入前胚胎囊胚的内细胞团。这些干细胞用于治疗各种疾病。

By Application
Regenerative Medicine
Stem Cell Biology Research
Tissue Engineering
Toxicology Testing
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of World

Report scope can be customized per your requirements. Click here.

主要市场趋势

干细胞生物学研究部门预计将在预测年份显示出更好的增长

根据应用,细分为再生医学、干细胞生物学研究、组织工程和毒理学检测。由于心脏病和恶性疾病的高发病率,干细胞生物学研究将显示出更好的增长。ISSCR(国际干细胞研究学会)发表的一篇文章报告说,干细胞具有治疗人类帕金森病的潜力。最近,市场参与者之一国际干细胞公司 (ISCO) 获得了一项专利,该专利涵盖了从未受精卵中产生 HLA 纯合孤雌生殖人类干细胞系的方法。该专利在澳大利亚颁发。此外,为了加快干细胞研究的步伐,政府正在为研究人员提供资助机会。因此,由于这些因素,

Human Embryonic Stem Cells Market 1

北美主导人类胚胎干细胞市场

由于广泛的研究活动以及该地区慢性病和遗传疾病的高负担,预计人类胚胎干细胞市场将在北美地区占据主导地位。美国还显示出其他疾病的高发病率,例如糖尿病、心脏病、肾功能衰竭和骨质疏松症。人类胚胎干细胞具有很高的用于治疗的潜力,并可能成为治疗这些疾病的标准。此外,FDA 已批准临床试验,表明使用干细胞。因此,预计这些因素将影响预测期内人类胚胎干细胞市场的增长。

Human Embryonic Stem Cells Market 2

竞争格局

进入人类胚胎干细胞市场的全球参与者包括Astellas Pharma Inc、PeproTech Inc、Lineage Cell Therapeutics Inc、默克集团、PromoCell GmbH、STEMCELL Technologies Inc、赛默飞世尔科技和 ViaCyte, Inc。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Cardiac and Malignant Diseases

      2. 4.2.2 Rising Demand for Regenerative Medicines

      3. 4.2.3 Increasing Support from Governments and Government and Private Institutions

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Procedure

      2. 4.3.2 Stringent Regulatory Guidelines

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Application

      1. 5.1.1 Regenerative Medicine

      2. 5.1.2 Stem Cell Biology Research

      3. 5.1.3 Tissue Engineering

      4. 5.1.4 Toxicology Testing

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Rest of World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Astellas Pharma Inc

      2. 6.1.2 PeproTech Inc

      3. 6.1.3 Lineage Cell Therapeutics Inc

      4. 6.1.4 Merck KGaA

      5. 6.1.5 PromoCell GmbH

      6. 6.1.6 STEMCELL Technologies Inc

      7. 6.1.7 Thermo Fisher Scientific

      8. 6.1.8 ViaCyte, Inc.

      9. 6.1.9 Takara Bio Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Human Embryonic Stem Cells Market market is studied from 2018 - 2026.

The Human Embryonic Stem Cells Market is growing at a CAGR of 9.29% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Merck KGaA, STEMCELL Technologies Inc., Thermo Fisher Scientific, Lineage cell therapeutics , ViaCyte Inc are the major companies operating in Human Embryonic Stem Cells Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!